[Mibelli's porokeratosis and actinic keratosis. Clinical, histological and ultrastructural considerations apropos of 1 case with degeneration].

PubWeight™: 0.79‹?›

🔗 View Article (PMID 736439)

Published in Ann Dermatol Venereol on March 13, 1979

Authors

G Manfredi, C Bordi, F Allegra

Articles citing this

Disseminated bilateral hyperkeratotic variant of porokeratosis Mibelli. Arch Dermatol Res (1987) 0.75

Articles by these authors

Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg (1996) 2.69

Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? J Psychopharmacol (2008) 2.07

Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology (1999) 1.66

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma. Ann Oncol (2005) 1.49

Serum osteocalcin and bone mineral density at various skeletal sites: a study performed with three different assays. J Lab Clin Med (1997) 1.43

Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. Ital J Gastroenterol Hepatol (1997) 1.40

Comments, opinions, and brief case reports: desmopressin test in occult eutopic corticotropin microadenoma. Arch Intern Med (2002) 1.40

[Who needs a gastroenterology pathologist?]. Pathologica (1996) 1.38

A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet (1999) 1.36

In vivo regulation of oxidative phosphorylation in cells harboring a stop-codon mutation in mitochondrial DNA-encoded cytochrome c oxidase subunit I. J Biol Chem (2001) 1.16

Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology (1991) 1.16

Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology (1998) 1.12

Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet (1995) 1.12

Maintenance of human rearranged mitochondrial DNAs in long-term cultured transmitochondrial cell lines. Mol Biol Cell (2000) 1.11

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer (2013) 1.10

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr Relat Cancer (2006) 1.10

Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology (1991) 1.10

Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review. Mod Pathol (2001) 1.09

Gastric endocrine cell proliferation. Association with Zollinger-Ellison syndrome. Arch Pathol (1974) 1.09

Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Dig Liver Dis (2011) 1.09

Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther (2000) 1.07

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy. Br J Cancer (2007) 1.07

Classification of gastric neuroendocrine tumors and its clinicopathologic significance. World J Gastroenterol (1998) 1.03

Composite carcinoid-adenocarcinoma of the stomach associated with multiple gastric carcinoids and nonantral gastric atrophy. Cancer (1989) 1.03

Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells. Hum Mol Genet (2009) 1.02

Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol (1997) 1.02

Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter (2001) 1.01

Role of Helicobacter pylori infection in pernicious anaemia. Dig Liver Dis (2000) 1.01

Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr (1992) 1.01

Heterotopic mesenteric ossification ('intraabdominal myositis ossificans'): report of five cases. Am J Surg Pathol (1999) 1.00

Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol (2001) 1.00

Letter: ECL cell proliferation and gastrin levels. Gastroenterology (1975) 1.00

RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours. J Pathol (2005) 0.99

Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther (2010) 0.98

High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am J Gastroenterol (1999) 0.98

Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter (1997) 0.98

Melancholia agitata and mixed depression. Acta Psychiatr Scand Suppl (2007) 0.97

Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach. Cell Tissue Res (1989) 0.96

Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology (1993) 0.96

Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther (2005) 0.95

Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab (1993) 0.94

Pathologic changes of endocrine cells in chronic atrophic gastritis. An ultrastructural study on peroral gastric biopsy specimens. Arch Pathol Lab Med (1978) 0.92

First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc (2001) 0.92

TorC apocytochrome negatively autoregulates the trimethylamine N-oxide (TMAO) reductase operon in Escherichia coli. Mol Microbiol (1999) 0.92

Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter? Eur J Echocardiogr (2008) 0.92

Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. J Pathol (1998) 0.91

Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp Neurol (2001) 0.91

Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin. Cancer (1992) 0.91

Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection. Aliment Pharmacol Ther (2001) 0.91

Efficient and specific amplification of identified partial duplications of human mitochondrial DNA by long PCR. Biochim Biophys Acta (1996) 0.90

Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. Bone (2000) 0.89

Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels. Transplantation (2000) 0.89

Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Correspondence with light microscopic findings. Gastroenterology (1990) 0.88

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost (2014) 0.88

Is tumour angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes? Eur J Surg (2000) 0.87

Highlights of the biology of endocrine tumours of the gut and pancreas. Endocr Relat Cancer (2003) 0.87

p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum Pathol (2001) 0.87

The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther (2002) 0.87

Oxyntic endocrine cells of hypergastrinaemic patients. Differential response to antrectomy or octreotide. Gut (1996) 0.86

Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J Clin Endocrinol Metab (1996) 0.86

RFLP analysis of human chromosome 11 region q13 in multiple symmetric lipomatosis and multiple endocrine neoplasia type 1-associated lipomas. Biochem Biophys Res Commun (1995) 0.86

Argyrophil cell hyperplasia of fundic mucosa in patients with chronic atrophic gastritis. Digestion (1986) 0.86

Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding. Am J Gastroenterol (1997) 0.86

Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest (1999) 0.85

[Thoracic actinomycosis with lung, mediastinal and pericardial involvement. A case report]. Recenti Prog Med (1995) 0.85

Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours. Gut (1998) 0.85

Human islet cell tumor storing pancreatic polypeptide: a light and electron microscopic study. J Clin Endocrinol Metab (1978) 0.85

Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage. Br J Dermatol (1979) 0.85

In situ identification of mononuclear cells infiltrating cutaneous carcinoma: an immuno-histochemical study. Acta Derm Venereol (1979) 0.84

Pancreatic-polypeptide cell hyperplasia associated with pancreatic or duodenal gastrinomas. Hum Pathol (1997) 0.84

Orthogonal arrays of particles in the gastric parietal cell of the rat: differences between superficial and basal cells in the gland and after pentagastrin or metiamide treatment. Anat Rec (1986) 0.84

Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment Pharmacol Ther (2011) 0.84

Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol (1996) 0.83

Pathology of endocrine cells in gastric mucosa. Ann Pathol (1983) 0.83

Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells. Virchows Arch A Pathol Anat Histol (1978) 0.83

Orthogonal arrays of particles in plasma membranes of the gastric parietal cell. Anat Rec (1978) 0.83

Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome. Hum Pathol (2000) 0.83

Ultrastructural and histological study of 11 bronchial carcinoids. Evidence for different types. Virchows Arch A Pathol Anat Histol (1979) 0.83

An in vivo method of studying the kinetics of cell proliferation in normal human epidermis. Acta Derm Venereol (1974) 0.83

Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. Ann Oncol (2003) 0.82

Fine structure of granular cell tumor of Abrikosov. J Cutan Pathol (1981) 0.82

Retinol binding protein in normal human skin and in cutaneous disorders. Br J Dermatol (1981) 0.82

Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma. Am J Clin Oncol (1999) 0.82

Generalized eruptive histiocytoma. A clinical, histologic, and ultrastructural study. Arch Dermatol (1981) 0.82

Imbalance in phenotypic expression of T cell subpopulations during different evolutional stages of lichen planus lesions. Acta Derm Venereol (1983) 0.82

Functional and morphologic characterization of human insulinomas. Diabetes (1983) 0.81

Calcitonin- and ACTH-producing cells in a case of medullary carcinoma of the thyroid. Immunofluorescence investigations. Virchows Arch A Pathol Pathol Anat (1973) 0.81

[Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis]. Verh Dtsch Ges Pathol (1996) 0.81

Solitary polypoid hamartoma of the oxyntic mucosa of the stomach. Pathol Res Pract (1987) 0.80

Primary osteosarcoma of the cervical spine causing neurological symptoms. Surg Neurol (1984) 0.80

Biclonality of gastric lymphomas. Lab Invest (2001) 0.80

Histologic, immunofluorescence, and ultrastructural study of malignant islet-cell tumors of the pancreas induced in hamsters by BK human papovavirus. Am J Pathol (1985) 0.80

Immunocytochemical localization of pyrazine-binding protein in bovine nasal mucosa. Cell Tissue Res (1987) 0.80

Multiple islet cell tumors with predominance of glucagon-producing cells and ulcer disease. Am J Clin Pathol (1987) 0.80